Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balzarini

Showing results (91-100 of 1,584) with videos related to

Pageof 159
Sort By:
Journal of the American Chemical Society|May 19, 2005
The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulationsFátima Rodríguez-Barrios, Jan Balzarini, Federico Gago
Bioorganic & Medicinal Chemistry|February 6, 2013
Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linkerKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Clinical Chemistry|April 1, 1992
Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detectionL Naesens, J Balzarini, E De Clercq
Gene Therapy|August 6, 1999
Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analoguesB Degrève, E De Clercq, J Balzarini
Antimicrobial Agents and Chemotherapy|April 1, 1995
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsJ Balzarini, M Baba, E De Clercq
The Journal of Biological Chemistry|March 25, 1993
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2J Balzarini, C Bohman, E De Clercq
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaquesJ Balzarini, E De Clercq, K Uberla
International Journal of Cancer|August 15, 1990
Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administeredJ Balzarini, L Naesens, E De Clercq
Antiviral Research|May 1, 1989
Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivoJ Balzarini, P Herdewijn, E De Clercq
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Pageof 159

Showing results (91-100 of 1,584) with videos related to

Sort By:
Pageof 159
Journal of the American Chemical Society|May 19, 2005
The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulationsFátima Rodríguez-Barrios, Jan Balzarini, Federico Gago
Bioorganic & Medicinal Chemistry|February 6, 2013
Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linkerKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Clinical Chemistry|April 1, 1992
Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detectionL Naesens, J Balzarini, E De Clercq
Gene Therapy|August 6, 1999
Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analoguesB Degrève, E De Clercq, J Balzarini
Antimicrobial Agents and Chemotherapy|April 1, 1995
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsJ Balzarini, M Baba, E De Clercq
The Journal of Biological Chemistry|March 25, 1993
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2J Balzarini, C Bohman, E De Clercq
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaquesJ Balzarini, E De Clercq, K Uberla
International Journal of Cancer|August 15, 1990
Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administeredJ Balzarini, L Naesens, E De Clercq
Antiviral Research|May 1, 1989
Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivoJ Balzarini, P Herdewijn, E De Clercq
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Pageof 159